- Home
- BTAI vs MIND Comparison
BTAI vs MIND Comparison
Compare BTAI & MIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- MIND
- Stock Information
- Founded
- BTAI 2017
- MIND 1987
- Country
- BTAI United States
- MIND United States
- Employees
- BTAI N/A
- MIND N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- MIND Industrial Machinery/Components
- Sector
- BTAI Health Care
- MIND Industrials
- Exchange
- BTAI Nasdaq
- MIND Nasdaq
- Market Cap
- BTAI 28.7M
- MIND 30.7M
- IPO Year
- BTAI 2018
- MIND 1994
- Fundamental
- Price
- BTAI $0.36
- MIND $6.86
- Analyst Decision
- BTAI Strong Buy
- MIND
- Analyst Count
- BTAI 4
- MIND 0
- Target Price
- BTAI $5.00
- MIND N/A
- AVG Volume (30 Days)
- BTAI 949.6K
- MIND 455.8K
- Earning Date
- BTAI 11-14-2024
- MIND 12-10-2024
- Dividend Yield
- BTAI N/A
- MIND N/A
- EPS Growth
- BTAI N/A
- MIND N/A
- EPS
- BTAI N/A
- MIND 6.61
- Revenue
- BTAI $2,276,000.00
- MIND $45,197,000.00
- Revenue This Year
- BTAI $164.86
- MIND $22.98
- Revenue Next Year
- BTAI $69.74
- MIND $10.18
- P/E Ratio
- BTAI N/A
- MIND $0.97
- Revenue Growth
- BTAI 83.25
- MIND 41.23
- 52 Week Low
- BTAI $0.35
- MIND $3.05
- 52 Week High
- BTAI $4.17
- MIND $7.39
- Technical
- Relative Strength Index (RSI)
- BTAI 32.49
- MIND 91.35
- Support Level
- BTAI $0.35
- MIND $5.55
- Resistance Level
- BTAI $0.52
- MIND $6.47
- Average True Range (ATR)
- BTAI 0.06
- MIND 0.43
- MACD
- BTAI -0.00
- MIND 0.34
- Stochastic Oscillator
- BTAI 2.92
- MIND 95.33
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About MIND MIND Technology Inc. (DE)
MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The Company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; Europe, Russia & CIS; Middle East & Africa; Asia-Pacific; and Canada & Latin America.